NO20050961L - R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning - Google Patents

R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning

Info

Publication number: NO20050961L
Authority: NO; Norway
Prior art keywords: amino; alkyl; hydroxypropanoic acid; gem; diphenyl
Prior art date: 2002-08-14

Application number

NO20050961A

Other languages

English (en)

Norwegian (no)

Inventor

Camille Georges Wermuth

Kathleen Clarence-Smith

Jean-Marie Georges Contreras

Laurence Nathalie Deyon

Original Assignee

Prestwick Pharmaceuticals Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-08-14

Filing date

2005-02-23

Publication date

2005-04-28

2005-02-23 Application filed by Prestwick Pharmaceuticals Inc filed Critical Prestwick Pharmaceuticals Inc

2005-04-28 Publication of NO20050961L publication Critical patent/NO20050961L/no

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/02—Systems containing only non-condensed rings with a three-membered ring

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Epidemiology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

NO20050961A 2002-08-14 2005-02-23 R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning NO20050961L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0210306A FR2843590B1 (fr)	2002-08-14	2002-08-14	Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
PCT/FR2003/002447 WO2004016580A2 (fr)	2002-08-14	2003-08-01	Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique

Publications (1)

Publication Number	Publication Date
NO20050961L true NO20050961L (no)	2005-04-28

Family

ID=30775996

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20050961A NO20050961L (no)	2002-08-14	2005-02-23	R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning

Country Status (19)

Country	Link
US (1)	US7488755B2 (fr)
EP (1)	EP1529030A2 (fr)
JP (1)	JP2005535715A (fr)
KR (2)	KR100756138B1 (fr)
CN (1)	CN1675169A (fr)
AU (1)	AU2003274213B2 (fr)
BR (1)	BR0313740A (fr)
CA (1)	CA2497347A1 (fr)
CR (1)	CR7736A (fr)
EA (1)	EA010417B1 (fr)
FR (1)	FR2843590B1 (fr)
GE (1)	GEP20074194B (fr)
IL (1)	IL166778A0 (fr)
MX (1)	MXPA05001761A (fr)
NO (1)	NO20050961L (fr)
NZ (1)	NZ538633A (fr)
PL (1)	PL375413A1 (fr)
UA (1)	UA80559C2 (fr)
WO (1)	WO2004016580A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2013072936A2 (fr) *	2011-11-10	2013-05-23	Ramamohan Rao Davuluri	Procédé inédit de préparation de (r)-n-benzyl-2-acétamido-3-méthoxypropionamide

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPH03236315A (ja) *	1989-12-05	1991-10-22	Nippon Oil & Fats Co Ltd	抗精神病薬
US5332758A (en) *	1990-07-13	1994-07-26	Kanebo, Ltd.	Collagen metabolism ameliorant and its use
ES2036926B1 (es) *	1991-08-08	1994-01-16	Uriach & Cia Sa J	"procedimiento para la obtencion de derivados de la (2-alquil-3-piridil)metilpiperazina".
GB9425730D0 (en)	1994-12-20	1995-02-22	Nycomed Pharma As	Compounds
WO1997020552A1 (fr) *	1995-12-07	1997-06-12	Albert Einstein College Of Medicine Of Yeshiva University	Traitement des symptomes negatifs et cognitifs de la schizophrenie a l'aide de glycine et de ses precurseurs
IT1283489B1 (it) *	1996-07-23	1998-04-21	Chiesi Farma Spa	Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
WO1999052519A2 (fr) *	1998-04-14	1999-10-21	The General Hospital Corporation	Methodes de traitement de troubles neuropsychiatriques
GB2410947B (en)	2004-02-11	2008-09-17	Cambridge Lab Ltd	Pharmaceutical compounds

2002
- 2002-08-14 FR FR0210306A patent/FR2843590B1/fr not_active Expired - Fee Related
2003
- 2003-01-08 UA UAA200501927A patent/UA80559C2/uk unknown
- 2003-08-01 EP EP03758195A patent/EP1529030A2/fr not_active Withdrawn
- 2003-08-01 CA CA002497347A patent/CA2497347A1/fr not_active Abandoned
- 2003-08-01 EA EA200500333A patent/EA010417B1/ru not_active IP Right Cessation
- 2003-08-01 AU AU2003274213A patent/AU2003274213B2/en not_active Ceased
- 2003-08-01 CN CNA038188481A patent/CN1675169A/zh active Pending
- 2003-08-01 KR KR1020057002073A patent/KR100756138B1/ko not_active Expired - Fee Related
- 2003-08-01 WO PCT/FR2003/002447 patent/WO2004016580A2/fr not_active Ceased
- 2003-08-01 US US10/524,869 patent/US7488755B2/en not_active Expired - Fee Related
- 2003-08-01 NZ NZ538633A patent/NZ538633A/en not_active IP Right Cessation
- 2003-08-01 KR KR1020077013426A patent/KR100890674B1/ko not_active Expired - Fee Related
- 2003-08-01 MX MXPA05001761A patent/MXPA05001761A/es active IP Right Grant
- 2003-08-01 JP JP2004528582A patent/JP2005535715A/ja active Pending
- 2003-08-01 BR BR0313740-6A patent/BR0313740A/pt not_active IP Right Cessation
- 2003-08-01 PL PL03375413A patent/PL375413A1/xx unknown
- 2003-08-01 GE GEAP8683A patent/GEP20074194B/en unknown
2005
- 2005-02-09 IL IL16677805A patent/IL166778A0/xx unknown
- 2005-02-23 NO NO20050961A patent/NO20050961L/no not_active Application Discontinuation
- 2005-03-11 CR CR7736A patent/CR7736A/es unknown

Also Published As

Publication number	Publication date
PL375413A1 (en)	2005-11-28
KR20070067250A (ko)	2007-06-27
BR0313740A (pt)	2005-07-19
UA80559C2 (en)	2007-10-10
CN1675169A (zh)	2005-09-28
AU2003274213A1 (en)	2004-03-03
NZ538633A (en)	2007-10-26
WO2004016580A2 (fr)	2004-02-26
CR7736A (es)	2008-10-10
MXPA05001761A (es)	2005-04-25
FR2843590A1 (fr)	2004-02-20
FR2843590B1 (fr)	2007-10-05
KR20050055697A (ko)	2005-06-13
GEP20074194B (en)	2007-09-10
CA2497347A1 (fr)	2004-02-26
IL166778A0 (en)	2006-01-15
EA200500333A1 (ru)	2005-08-25
WO2004016580A3 (fr)	2004-04-08
KR100756138B1 (ko)	2007-09-05
US7488755B2 (en)	2009-02-10
KR100890674B1 (ko)	2009-03-26
JP2005535715A (ja)	2005-11-24
US20050261372A1 (en)	2005-11-24
EP1529030A2 (fr)	2005-05-11
AU2003274213B2 (en)	2008-03-13
EA010417B1 (ru)	2008-08-29

Similar Documents

Publication	Publication Date	Title
BR0312729A (pt)	2005-05-10	Novos derivados de indol-3-enxofre
BR0015624A (pt)	2002-07-30	Uso de um composto, composto, composição farmacêutica, e, método de tratamento ou profilaxia de doenças ou condições humanas
BRPI0413695A (pt)	2006-10-24	derivados de naftiridina substituìda como inibidores do fator inibidor da migração de macrófagos e seu uso no tratamento de doenças humanas
NO20062370L (no)	2006-07-18	Amidderivater
AU2003225617A1 (en)	2003-09-16	Thiadiazolylpiperazine derivatives useful for treating or preventing pain
NO20076319L (no)	2007-12-07	Farmasoytiske sammensetninger av et neuroaktivt steroid og anvendelse derav
MY138352A (en)	2009-05-29	Benzothiazole derivatives
JO2282B1 (en)	2005-09-12	Oxazole derivatives
WO2003000343A3 (fr)	2004-03-25	Administration d'inhibiteurs de phosphodiesterase destinee au traitement de l'ejaculation precoce
NO331002B1 (no)	2011-09-05	Tioxantinderivater og farmasoytiske preparater med tioxantinderivater
BR0313407A (pt)	2005-07-05	Novo uso de derivados de benzotiazol
MA27702A1 (fr)	2006-01-02	Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation
ES2098947T3 (es)	1997-05-01	Derivados de beta,beta-dimetil-4-piperidinoetanamina como inhibidores de la biosintesis del colesterol.
NO20024324D0 (no)	2002-09-10	Legemidler for diagnose av vevsreproduktiv aktivitet eller behandling av proliferative sykdommer
CA2302568A1 (fr)	1999-03-18	Procede, compositions et trousses servant a augmenter la biodisponibilite orale d'agents pharmaceutiques
HUP0104963A2 (hu)	2002-04-29	Bőrbetegségek kezelésére szolgáló készítmények
DE59905075D1 (de)	2003-05-22	S-substituierte 11beta-benzaldoxim-estra-4,9-dien-kohlensäurethiolester, verfahren zu deren herstellung und diese verbindungen enthaltene pharmazeutische zubereitungen
ATE366107T1 (de)	2007-07-15	Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
BRPI0416882A (pt)	2007-02-27	composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto
PL360492A1 (en)	2004-09-06	Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
CA2143252A1 (fr)	1995-08-26	Derives de benzodioxane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
HUP0104308A2 (hu)	2002-04-29	Amidino- és guanidino-azetidinon-származékok, mint triptáz inhibitorok, eljárás előállításukra, ezeket tartalmazó gyógyszerkészítmények, valamint intermedierek
NO20050961L (no)	2005-04-28	R(+)-2-Amino-3-Hydroksypropansyrederivater med glysinergisk virkning
MX2007006744A (es)	2007-07-09	Derivados de hidantoina utiles como inhibidores de metaloproteinasa.
SE9903611D0 (sv)	1999-10-06	Novel compounds III

Legal Events

Date	Code	Title	Description
2013-03-25	FC2A	Withdrawal, rejection or dismissal of laid open patent application